Ellsworth Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,344
Closed -$306K 172
2023
Q3
$306K Buy
6,344
+169
+3% +$10K 0.11% 144
2023
Q2
$415K Buy
+6,175
New +$377K 0.14% 116
2021
Q4
Sell
-9,683
Closed -$514K 167
2021
Q3
$514K Buy
9,683
+392
+4% +$22.1K 0.23% 80
2021
Q2
$567K Buy
+9,291
New +$494K 0.28% 71

Other funds holding LMAT

Ellsworth Advisors's LMAT Position: Q4 2023 in Review

Ellsworth Advisors sold out of LeMaitre Vascular (LMAT) in Q4 2023, closing a stake of 6,344 shares — an estimated $306K sold.

Ellsworth Advisors first reported a position in LMAT in Q2 2021 and held it in 4 quarters. The position peaked at $567K in Q2 2021. 227 funds tracked by Wall St. Rank hold LMAT as of Q4 2023.

  • Ellsworth Advisors reported no remaining LeMaitre Vascular position as of Q4 2023 after selling out during the quarter.
  • Ellsworth Advisors sold 6,344 LeMaitre Vascular shares in Q4 2023, an estimated $306K.
  • Ellsworth Advisors first reported a position in LeMaitre Vascular in Q2 2021 and held it in 4 quarters.
  • Ellsworth Advisors's LeMaitre Vascular position peaked at $567K in Q2 2021.
  • 227 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2023.

Based on Ellsworth Advisors's 13F filing for Q4 2023, filed 18 Jan 2024.